Fonte: Journal of Controlled Release. Unidade: FCF
Assuntos: FARMACOCINÉTICA, NANOTECNOLOGIA, CÁPSULAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
GARCIA, Giani Martins et al. Improved nonclinical pharmacokinetics and biodistribution of a new PPAR pan-agonist and COX inhibitor in nanocapsule formulation. Journal of Controlled Release, v. 209, p. 207-218, 2015Tradução . . Disponível em: https://doi.org/10.1016/j.jconrel.2015.04.033. Acesso em: 23 ago. 2024.APA
Garcia, G. M., Oliveira, L. T., Pitta, I. da R., Lima, M. do C. A. de, Vilela, J. M. C., Andrade, M. S., et al. (2015). Improved nonclinical pharmacokinetics and biodistribution of a new PPAR pan-agonist and COX inhibitor in nanocapsule formulation. Journal of Controlled Release, 209, 207-218. doi:10.1016/j.jconrel.2015.04.033NLM
Garcia GM, Oliveira LT, Pitta I da R, Lima M do CA de, Vilela JMC, Andrade MS, Abdalla DSP, Mosqueira VCF. Improved nonclinical pharmacokinetics and biodistribution of a new PPAR pan-agonist and COX inhibitor in nanocapsule formulation [Internet]. Journal of Controlled Release. 2015 ; 209 207-218.[citado 2024 ago. 23 ] Available from: https://doi.org/10.1016/j.jconrel.2015.04.033Vancouver
Garcia GM, Oliveira LT, Pitta I da R, Lima M do CA de, Vilela JMC, Andrade MS, Abdalla DSP, Mosqueira VCF. Improved nonclinical pharmacokinetics and biodistribution of a new PPAR pan-agonist and COX inhibitor in nanocapsule formulation [Internet]. Journal of Controlled Release. 2015 ; 209 207-218.[citado 2024 ago. 23 ] Available from: https://doi.org/10.1016/j.jconrel.2015.04.033